Meta-analysis of the placebo response in antidepressant trials

Journal of Affective Disorders

Volumn 118, Issue 1-3, 2009, Pages 1-8

  Rief, Winfried ^a   Nestoriuc, Yvonne ^a   Weiss, Sarah ^a   Welzel, Eva ^a   Barsky, Arthur J ^b   Hofmann, Stefan G ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Antidepressant; Depression; Meta analysis; Placebo

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

BECK DEPRESSION INVENTORY; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEPRESSION; DRUG EFFECT; EFFECT SIZE; HAMILTON SCALE; HUMAN; MEDLINE; MENTAL DISEASE; META ANALYSIS; OUTCOME VARIABLE; PLACEBO EFFECT; PRIORITY JOURNAL; PSYCINFO; PUBLICATION; QUALITY OF LIFE; RATING SCALE; RESEARCH; REVIEW; SELF REPORT; SENSITIVITY ANALYSIS; SYMPTOM CHECKLIST 90; SYSTEMATIC REVIEW; VALIDITY;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 69949169319     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.01.029     Document Type: Review

References (40)

1. Antonaci F., Chimento P., Diener H.C., Sances G., and Bono G. Lessons from placebo effects in migraine treatment. Journal of Headache and Pain 8 (2007) 63-66
2. Beck A.T., and Steer R.A. Beck Depression Inventory. Manual (1987), The Psychological Cooperation, San Antonio
3. Becker B.J. Synthesizing standardized mean-change measures. British Journal of Mathematical and Statistical Psychology 41 (1988) 257-278
4. Benedetti F. The opposite effect of the opiate antagonist naloxon and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64 (1996) 535-543
5. Benedetti F., Pollo A., Lopiano L., Lanotte M., Vighetti S., and Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. Journal of Neuroscience 23 (2003) 4315-4323
6. Benedetti F., Arduino C., Costa S., Vighetti S., Tarenzi L., Rainero I., and Asteggiano G. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain 121 (2006) 133-144
7. Bingel U., Lorenz J., Schoell E., Weiller C., and Büchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120 (2006) 8-15
8. Cohen J. Statistical Power Analysis for the Behavioral Sciences (1988), Erlbaum Academic Press, Hillsdale, NJ
9. Derogatis L.R. SCL-90. Administration, Scoring and Procedures (1994), Author, Massachussetts
10. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 7 (1986) 177-188
11. Egger M., Smith G.D., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315 (1997) 629-634
12. Fava M., Eden Evins A., Dorer D.J., and Schoenfeld D.A. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychotherapy and Psychosomatics 72 (2003) 115-127
13. Gehr B.T., Weiss C., and Porzsolt F. The fading of reported effectiveness. A meta-analysis of randomised controlled trials. BMC Medical Research Methodology 6 (2006) 10.1186/1471-2288-1186-1125
14. Hartmann A., Herzog T., and Drinkmann A. Psychotherapy of bulimia nervosa: what is effective?. Journal of Psychosomatic Research 36 (1992) 159-167
15. Hedges L.V., and Olkin I. Statistical Methods for Meta-analysis (1985), Academic Press, Orlando, Fla
16. Hróbjartsson A., and Gøtzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine 344 (2001) 1594-1602
17. Huppert J.D., Schultz L.T., Foa E.B., Barlow D.H., Davidson J.R.T., Gorman J.M., Shear M.K., Simpson H.B., and Woods S.W. Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. American Journal of Psychiatry 161 (2004) 1485-1487
18. Jadad A.R., Moore R.A., Carroll D., Jenkinson C.P., Reynolds D.J., Gavaghan D.J., and McQuai H.J. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 17 (1996) 1-12
19. Joffe R.T., Sokolov S., and Streiner D. Antidepressant treatment of depression: a meta-analysis. Canadian Journal of Psychiatry 41 (1996) 613-616
20. Kahn A., Warner H.A., and Brown W.A. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Archives of General Psychiatry 57 (2000) 311-317
21. Khan A., Schwartz K., Kolts R.L., and Ridgway D.L.C. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes. Biological Psychiatry 62 (2007) 65-71
22. Kirsch I., and Sapirstein G. Listening to prozac but hearing placebo: a meta-analysis of antidepressant medication. Prevention and treatment 1(article 0002a) (1998)
23. Kirsch I., Moore T.J., Scoboria A., and Nicholls S.S. The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. food and drug administration. Prevention and Treatment 5(article 23) (2002)
24. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., and Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLOS Medicine 5 2 (2008) e45
25. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., and Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry 159 (2002) 122-129
26. Levine M.E., Stern R.M., and Koch K.L. The effects of manipulating expectations through placebo and nocebo administration on gastric tachyarrhythmia and motion-induced nausea. Psychosomatic Medicine 68 (2006) 478-486
27. Mayberg H.S., Silva J.A., Brannan S.K., Tekell J.L., Mahurin R.K., McGinnis S., and Jerabek P.A. The functional neuroanatomy of the placebo effect. American Journal of Psychiatry 159 (2002) 728-737
28. McRae C., Cherin E., Yamazaki T.G., Diem G., Vo A.H., Russell D., Ellgring J.H., Fahn S., Greene P., Dillon S., Winfield H., Bjugstad K.B., and Freed C.R. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Archives of General Psychiatry 61 (2004) 412-420
29. Moncrieff J., Wessely S., and Hardy R. Active placebos versus antidepressants for depression. The Cochrane Database of Systematic Review (1) (2004)
30. Moseley J.B., O'Malley K., Petersen N.J., Menke T.J., Brody B.A., Kuykendall D.H., Hollingsworth J.C., Ashton C.M., and Wray N.P. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. New England Journal of Medicine 347 (2002) 81-88
31. Petrovic P., Kalso E., Petersson K.M., and Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science 295 (2002) 1737-1740
32. Preston R.A., Materson B.J., Reda D.J., and Williams D.W. Placebo-associated blood pressure response and adverse effects in the treatment of hypertension. Archives of Internal Medicine 160 (2000) 1449-1454
33. Rapaport M.H., Pollack M., Wolkow R., Mardekian J., and Clary C. Is placebo response the same as drug response in panic disorder?. American Journal of Psychiatry 157 (2000) 1014-1016
34. Rhebergen D., Beekman A.T.F., de Graaf R., Nolen W.A., Spijker J., Hoogendijk W.J., and Pennix B.W.J.H. The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression. Journal of Affective Disorders 115 3 (2009) 450-459
35. Rush A.J. Clinical Practice Guideline 5. Depression in Primary Care Vol. 2. Treatment of Major Depression (1993), AHCPR Silver Spring
36. Stoolmiller M., Kim H.K., and Capaldi D.M. The course of depressive symptoms in men from early adolescence to young adulthood: identifying latent trajectories and early predictors. Journal of Abnormal Psychology 114 (2005) 331-345
37. Turner E.H., Mathhews A.M., Linardatos E., Tell R.A., and Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine 358 (2008) 252-260
38. Waber R.L., Shiv B., Carmon Z., and Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA 299 (2008) 1016-1017
39. Walsh B.T., Seidman S.N., Sysko R., and Gould M. Placebo response in studies of major depression: variable, substantial, and growing. Journal of the American Medical Association 287 (2002) 1840-1847
40. Zung W.W.K. A self-rating depression scale. Archives of General Psychiatry 12 (1965) 63-70